Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Catheter Precision Inc VTAK

Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.


NYSEAM:VTAK - Post by User

Post by averagepennieson Dec 05, 2023 11:13am
29 Views
Post# 35769078

Catheter Precision, Inc. (NYSE American:VTAK) Presenting at

Catheter Precision, Inc. (NYSE American:VTAK) Presenting at

FORT MILL, SC / ACCESSWIRE / December 5, 2023 / Catheter Precision, Inc. (NYSE American:VTAK) is pleased to announce that it has been invited to present at the Emerging Growth Conference on December 6, 2023. Catheter Precision, Inc. (NYSE American: VTAK) will be discussing VIVO™, its innovative non-invasive, 3D mapping system that enables physicians to identify the origin of ventricular cardiac arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. VIVO received marketing clearance from the U.S. FDA and is commercially available in Europe. VIVO is designed to provide an innovative cost-effective solution for improving the treatment of cardiac arrhythmias among other company topics.

This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chief Executive Officer in real time. Individual and institutional investors, as well as advisors and analysts, are invited to attend its real-time, interactive presentation at the Emerging Growth Conference.

David Jenkins, CEO will give a presentation and may subsequently open the floor for questions. Please submit your questions in advance to Questions@EmergingGrowth.com or ask your questions during the event and he will do his best to get through as many of them as possible.

Catheter Precision, Inc. (NYSE American:VTAK) will be presenting at 11:25am Eastern time for 30 minutes.

Please register here to ensure you can attend the conference and receive any updates that are released.

https://emerginggrowth.com/emerging-growth-conference-65/

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, https://www.YouTube.com/EmergingGrowthConference. We will release a link to that after the event.

 

https://www.accesswire.com/813088/catheter-precision-inc-nyse-americanvtak-presenting-at-the-emerging-growth-conference-on-december-6-2023

<< Previous
Bullboard Posts
Next >>